Polaris AI Pharma Corp. (041910) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Polaris AI Pharma Corp. (041910:KRX), powered by AI.

Current Price
₩5,320
P/E Ratio
11.5
Market Cap
70.7B
Sector
Common Stock
What is the Polaris AI Pharma Corp. stock price forecast?

Polaris AI Pharma Corp. is currently trading at ₩5,320. View real-time AI analysis on Alpha Lenz.

What is Polaris AI Pharma Corp. insider trading activity?

View the latest insider trading data for Polaris AI Pharma Corp. on Alpha Lenz.

What is Polaris AI Pharma Corp.'s P/E ratio?

Polaris AI Pharma Corp.'s P/E ratio is 11.5.

Polaris AI Pharma Corp.

KRX · 041910
₩5,320+10(+0.19%)Market closedKRX regular session 09:00–15:30 KST
Ask about Polaris AI Pharma Corp.'s future dividend policy...
Alpha Chat Insight

Polaris AI Pharma Corp. trades at a P/E of 11.5 (undervalued) with modest ROE of 4.7%.

Ask for details

Company Overview

Polaris AI Pharma Corp., a biotechnology company, is at the forefront of integrating artificial intelligence with pharmaceutical research and development. Its primary purpose is to enhance drug discovery and streamline development processes, aiming to bring effective treatments to market more efficiently. Utilizing cutting-edge AI algorithms, Polaris AI Pharma Corp. manages vast datasets to identify potential drug candidates and predict their interactions and efficacy with unprecedented accuracy. The company's work significantly impacts sectors such as oncology, neurology, and cardiovascular diseases, addressing complex medical challenges with innovative solutions. As a player in the biotech industry, Polaris AI Pharma Corp. plays a vital role in advancing medical technology and paving the way for personalized medicine, ultimately seeking to improve patient outcomes on a global scale.

CEO김영관
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩70,667,422,000Market Cap
₩55,543,077,000Revenue
13.28MShares Out
0Employees

Margins

22.08%Gross
11.11%EBITDA
5.74%Operating
13.68%Pre-Tax
11.09%Net

Valuation

11.47P/E
0.52P/B
1.27EV/Sales
15.35EV/EBITDA
8.54P/FCF

Growth (CAGR)

-3.62%Rev 3Yr
-1.96%Rev 5Yr
0.28%Op Inc 3Yr
-17.28%Op Inc 5Yr
N/ANet Inc 3Yr
-17.10%Net Inc 5Yr

Returns

3.73%ROA
4.66%ROE
4.62%ROIC

Financial Health

₩26,752,536,870Cash & Cash Equivalents
₩33,249,187,630Net Debt
44.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Polaris AI Pharma Corp. (ticker: 041910) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $70.7B.

The current price is ₩5,320 with a P/E ratio of 11.47x and P/B of 0.52x.

ROE is 4.66% and operating margin is 5.74%. Annual revenue is $55.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Polaris AI Pharma Corp. (041910) Stock Forecast 2026 ₩5,320 — Price, Financials & Analyst Targets | Alpha Lenz